top of page
News, Events and Updates
Search
Jan 11, 2016
Anavex Announces Positive Dose-Response Data for ANAVEX 2-73 in Alzheimer's Disease Patients
Jan 11, 2016
New Alzheimer's Drug ANAVEX 2-73: A Phase 2a Study, Clinical Safety, and Tolerability
Jan 8, 2016
Anavex Issues Statement Addressing Recent Press Releases by Law Firms
Dec 29, 2015
Anavex Announces Fiscal 2015 Year-End Financial Results
Dec 11, 2015
Novel Anti-Seizure Compound ANAVEX 2-73 a Sigma-1 Receptor Agonist in Multiple Seizure Models
Dec 8, 2015
Third Annual MHPAEA Business Roundtable
Dec 8, 2015
ICV Manhattan 2015
Dec 8, 2015
American Epilepsy Society Annual Meeting
Dec 7, 2015
Anavex to Present at Third Annual MHPAEA Business Roundtable in Washington, D.C.
Dec 2, 2015
Anavex Expands Management Team
Nov 30, 2015
Independent Research Describes ANAVEX 3-71 as Potent Cognitive Enhancer in Alzheimer's Disease Model
29
30
31
32
33
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
